HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

(-)Deprenyl-N-oxide, a (-)deprenyl metabolite, is cytoprotective after hypoxic injury in PC12 cells, or after transient brain ischemia in gerbils.

AbstractBACKGROUND AND AIMS:
(-)-Deprenyl (selegiline) possesses cyto-protective effect in a much lower concentration, than it is needed to inhibit MAO-B activity. In permanent MCA occlusion stroke model in rats, the infarct volume and the number of apoptotic neurons in the penumbra region were decreased by low concentration (-)deprenyl treatment. Augmented Bcl-2 protein expression was documented as the responsible factor of this effect. The stabilization of mitochondrial membrane and diminished ROS production are the further possible consequences of (-)deprenyl treatment. It is not clear however that (-)deprenyl, or its metabolites are the acting neuroprotective molecules in the hypoxic/ischemic conditions. We report here the possible cyto-protective effect of deprenyl-N-oxide (DNO), a recently synthesized (-)deprenyl metabolite.
METHODS:
DNO in a very low dose (10(-5,-8,-12) M) was tested in PC12 cell culture after hypoxia and in gerbils after transient occlusion of bilateral common carotid artery. In PC12 culture the cell death was visualized by PI staining. The level of reactive oxygen species was measured by the Cerium method, and the mitochondrial membrane integrity was labeled by JC1 staining. Apoptotic neurons were counted on formaldehyde fixed gerbil brain slices after TUNEL and caspase-3 immune-staining - NIKON/BIORAD confocal microscopy was used for the quantitative analysis.
RESULTS:
DNO treatment significantly decreased the frequency of cell death in PC12 cultures after hypoxia, increased the mitochondrial transmembrane potential (DeltaY(m)) and decreased the ROS production. In the CA2 regions of gerbil hippocampus, we found significantly less apoptotic neurons than in the untreated controls.
CONCLUSION:
Transient hypoxia or ischemia induced cell damage could be diminished by DNO. This (-)deprenyl metabolite is an active cell protective molecule.
AuthorsGéza Szilágyi, László Simon, Edina Wappler, Kálmán Magyar, Zoltán Nagy
JournalJournal of the neurological sciences (J Neurol Sci) Vol. 283 Issue 1-2 Pg. 182-6 (Aug 15 2009) ISSN: 1878-5883 [Electronic] Netherlands
PMID19332347 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Neuroprotective Agents
  • Reactive Oxygen Species
  • deprenyl-N-oxide
  • Selegiline
Topics
  • Animals
  • Apoptosis (drug effects)
  • Brain Ischemia (drug therapy, pathology, physiopathology)
  • Carotid Artery Diseases (drug therapy, pathology, physiopathology)
  • Cell Death (drug effects)
  • Cell Hypoxia (drug effects)
  • Gerbillinae
  • Hippocampus (drug effects, pathology)
  • Mitochondrial Membranes (drug effects, physiology)
  • Neurons (drug effects, physiology)
  • Neuroprotective Agents (administration & dosage, pharmacology)
  • PC12 Cells
  • Rats
  • Reactive Oxygen Species (metabolism)
  • Selegiline (administration & dosage, analogs & derivatives, pharmacology)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: